NHS Framework Agreement for the supply of Ranibizumab for the NHS in England

NHS England · Closed

Buyer
NHS England
Status
Closed
Country
United Kingdom
Region
England
Sector
Manufacturing
Reference
FaT-ocds-h6vhtk-0395f7
Published
2023-01-09
Deadline
2023-02-10

Tender summary

The Procurement relates to the supply of ranibizumab an Anti Veg-F medicine used in medical retinal vascular services for the NHS in England. Anti Veg-F medicines are currently used in the treatment of: a. neovascular (wet) age-related macular degeneration (AMD); b. visual impairment due to diabetic macular oedema (DME/DMO); c. visual impairment due to myopic choroidal neovascularisation (myopic CNV); and d. visual impairment due to macular oedema secondary to retinal vein occlusion (branch RVO or central RVO).

This is a public summary of a procurement notice. Dates and status reflect the notice held by BidScout; check the full notice before bidding.

Full tender details have a three-minute guest preview for open opportunities. AI insights require registration.

Register for full access

IT tenders · Construction tenders · Sitemap